Streetbeat News

Regulatory

WNW

Meiwu Technology has received a notification letter from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:08 pm

DRMA

Dermata Therapeutics announced on June 4 that it has received a letter from Nasdaq confirming that the company has regained compliance with the minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:07 pm

ACHR

Archer Aviation has received a Part 135 Air Carrier and Operator Certificate from the FAA, allowing the company to begin operating as a commercial airline.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:05 pm

BYDDY

NIO

TSLA

NIO and BYD have received approval from Chinese regulators to test their automated driving technology on public roads. This approval marks the first instance of Chinese authorities approving testing for level 3 and level 4 automated driving technologies. Tesla is also preparing to register its 'Full Self-Driving' software in China, highlighting the competitive race in the autonomous driving sector.

Portfolio Pulse from Benzinga Neuro

June 05, 2024 | 1:04 pm

ABBV

AbbVie has initiated the treatment of the first patient with its investigational drug ABBV-383 in the Phase 3 CERVINO study for relapsed/refractory multiple myeloma. The study will compare the efficacy, safety, and tolerability of ABBV-383 monotherapy against standard available therapies in patients who have undergone at least two prior treatments.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:02 pm

CNSP

Trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. The news and resumption times are provided.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:55 pm

CRKN

Crown Electrokinetics has filed a prospectus for the potential resale of up to 300 million shares of common stock by Keystone Capital Partners. This filing was made with the SEC.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:45 pm

ZH

Zhihu has received a letter from the NYSE indicating that it has regained compliance with the NYSE ADS trading price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:44 pm

ISRG

Intuitive Surgical (NASDAQ: ISRG) received FDA clearance for revised labeling of its da Vinci X and Xi systems for radical prostatectomy, based on real-world evidence showing similar long-term survival rates to non-robotic procedures.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:42 pm

MCD

McDonald's Corp. (NYSE:MCD) has lost the trademark rights to its Chicken Big Mac in the European Union due to insufficient evidence of continuous use. The ruling, made by the EU's General Court, does not affect the traditional beef Big Mac trademark. The decision can still be appealed.

Portfolio Pulse from Benzinga Neuro

June 05, 2024 | 12:36 pm